Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.

Clinical trial NCT05189483 · UNKNOWN

Trial details

NCT number: NCT05189483
Sponsor: Henan Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma

Start date: 2022-01-01
Primary completion: 2024-07-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.